David Arkowitz, CFO at Flexion Therapeutics, holds 18.38K shares in Ibio (Ticker: IBIO), holds 182.44K shares in Seres Therapeutics (Ticker: MCRB), holds 0.00 shares in F-star Therapeutics (Ticker: FSTX). Most recently, David Arkowitz Bought ― shares of Ibio on Jan 13, 2025 for an estimated value of 50.00K.
David Arkowitz latest transaction was an Informative Buy of $50.00K.
What was David Arkowitz's most profitable transaction?
David Arkowitz’s most profitable transaction was an Informative Buy of FLXN stock on June 3, 2019. The return on the trade was 9.30%.
What is David Arkowitz's role in Flexion Therapeutics?
David Arkowitz's role in Flexion Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.